WearDOXX

What it does

WearDOXX is developing a non-invasive diagnostic platform that uses a wearable patch to collect sweat biomarkers. The patch contains nanosensors that detect biomarkers such as glucose and cortisol, which are linked to diseases including autoimmune disorders, Alzheimer's, epilepsy, and breast cancer. Users scan the patch with a smartphone app, and the results are sent to physicians for analysis. The platform is powered by AI and aims to detect disease before symptoms appear.

Who it is for

The product is designed for individuals who want proactive health monitoring, as well as healthcare professionals who need real-time, actionable insights into patients' physiological signals. The company emphasizes emotional empowerment, turning health anxiety into assurance. It is also positioned for partners in research and clinical settings.

Why it matters

Traditional diagnostics often require waiting for symptoms or lab visits. WearDOXX aims to shift from reactive to preventive care by providing continuous, real-time monitoring. The non-invasive nature (sweat-based, no needles) and smartphone integration make it accessible and convenient. Early detection of conditions like Alzheimer's or breast cancer could significantly improve outcomes.

Launch signal

The website indicates the company is a York University spinout, currently in seed stage. The founder is Razieh Salahandish. The site lists research, publications, and a team, suggesting active development. However, no specific launch date, clinical trial results, or commercial availability are mentioned in the available material.

Brand and naming

The name "WearDOXX" combines "wearable" with a stylized "DOXX" that may evoke "docs" (doctors) or "docks" (connection). The tagline "The Future of Disease Detection is Worn Not Waited For" reinforces the value proposition of proactive, wearable diagnostics. The brand positions itself as science-backed and AI-driven, with a focus on lifestyle integration and peace of mind.